-Item 5.02 Compensatory Arrangements of Certain Officers.
On May 30, 2013 Bio Matrix Scientific Group, Inc (the “Company”) issued to David R. Koos, the Company’s Chairman and Chief Executive Officer, 40,000 shares of the Company’s Series AAA Preferred Stock in satisfaction of $10,000 of accrued but unpaid salary due to David Koos.
-Item 8.01 Other Events
On May 29, 2013 J. Christopher Mizer was dismissed from his position as president of the Company’s wholly owned subsidiary, Regen BioPharma Inc. The position of president of Regen BioPharma Inc. has been assumed by David R. Koos, the Company’s Chairman and Chief Executive Officer.
www.otcmarkets.com/edgar/GetFilingHtml?FilingID=9330861